Sign in

CIK 0001404281

  • Non-accelerated filer
  • Smaller reporting company

Eledon Pharmaceuticals, Inc.

Sign in to watch
Ticker
ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 949-238-8090
Business address
19800 MACARTHUR BLVD., SUITE 250, IRVINE, CA, 92612
Former names
Eledon Pharmaceuticals, Inc., Novus Therapeutics, Inc., Tokai Pharmaceuticals Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-06-15 Harrison Seth Loring Director Grant or award · Stock Option (right to buy) +12,000 12,000
2015-06-17 Harrison Seth Loring Director Grant or award · Stock Option (right to buy) +12,000 12,000
2014-09-22 Harrison Seth Loring Director Conversion +7,549,570 7,549,579
2014-09-22 Harrison Seth Loring Director Purchase +362,500 $15.00 $5.4M 7,912,079
2014-09-22 Harrison Seth Loring Director Conversion · Series A Preferred Stock −4,500,000 0
2014-09-22 Harrison Seth Loring Director Conversion · Series B-1 Preferred Stock −798,067 0
2014-09-22 Harrison Seth Loring Director Conversion · Series B-2 Preferred Stock −644,786 0
2014-09-22 Harrison Seth Loring Director Conversion · Series C Preferred Stock −14,604,833 0
2014-09-22 Harrison Seth Loring Director Conversion · Series D-1 Preferred Stock −8,711,335 0
2014-09-22 Harrison Seth Loring Director Conversion · Series D-2 Preferred Stock −1,539,643 0
2014-09-22 Harrison Seth Loring Director Conversion · Series D-3 Preferred Stock −24,046,035 0
2014-09-22 Harrison Seth Loring Director Conversion · Series E Preferred Stock −24,199,308 0

Page 1 of 1 · 12 trades